Their results showed that SLC6A14 mRNA expression in CF nasal epithelia and in the pancreas colocalize with the lung disease and MI-associated variants, respectively, suggesting that each locus impacts SLC6A14 expression with tissue specificity. The gene discussed is SLC6A14; the disease is lung disorder.